Santa Cruz Biotechnology offers a broad range of RT1-B monoclonal antibodies for investigating RT1-B protein function. RT1-B monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). RT1-B protein functions as a critical component of the major histocompatibility complex (MHC) class I molecules, playing a vital role in the immune response by presenting peptide antigens to CD8+ T cells. RT1-B activity is essential for the recognition of infected or malignant cells, making it a key player in immune surveillance and response. Understanding RT1-B dynamics advances research in immunology and supports the development of therapeutic strategies for various diseases. RT1-B research contributes to breakthroughs in autoimmune disorders, transplantation biology, and cancer immunotherapy. Investigating RT1-B expression patterns helps reveal fundamental mechanisms of immune system regulation and cellular communication. RT1-B monoclonal antibodies from Santa Cruz Biotechnology enable researchers worldwide to advance scientific understanding of immune system function and disease mechanisms.